380 |
120 |
1.15
Lakh |
Private
institutes |
Public
institutes |
Number
of students |
![](http://www.biospectrumindia.com/images/content/2010/aug/Biotech%20Education%20Market%20in%20India%20garners%20over.jpg)
The Biotech Education Market in India in 2009 wasworth
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
1,050.72 crore with over one lakh students studying in more than 500
institutes. According to BioSpectrum estimates, about 380 private
institutes are offering under graduate, post graduate, MPhil and PhD
courses and 120 public institutes are offering post graduate and PhD
courses. The private institutions are collecting an average fee
of
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
3.2 lakh per course per student except few institutions that
are charging higher fees-in some cases over three times the average.
While a student pursuing masters from a public institute pays just
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
49,200 for the two-year course, students opting to study biotechnology
at private institutes pay as high as six-and-a-half times the fees the
public institutes are charging, according to the results of the 6th
BioSpectrum Top 20 BT Schools Survey. Forty nine public and private
institutes actively participated in the 2010 survey.
Some of the premier universities such as Jawaharlal Nehru University
are charging a meager fee of
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
1,391 for the entire course of
two-years. Similarly, other leading universities such as Cochin
University of Science and Technology, MS University of Baroda, Banaras
Hindu University are offering the biotechnology courses to students at
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
6,190,
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
4,260 and
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
8,858 for the entire course. The public
universities are able to offer the biotechnology courses at an
affordable fee to the students as these are receiving grants from
different government agencies.
In private institutes category, Shree Manibhai Virani & Smt
Navalben Virani Science College has been charging about
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
21,000 per
annum. Sitadevi Ratanchand Nahar Adarsh College and Maharani Lakshmi
Ammanni College For Women are offering Biotechnology courses at
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
28,000
per annum. The Biotech course at Gokaraju Rangaraju Institute of
Engineering and Technology and Arunai Engineering College is being
offered to students at
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
30,000 per annum and
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
32,500 per annum
respectively. While other institutes in private sector are offering the
course at higher fees with over Rs one lakh per annum.
These 49 institutes have 1,054 full time faculty of which 706 are PhDs
holders. About 822 are teaching at the private institutes and 232 are
teaching at the public institutes. The private institutions have
published 459 papers in the national journals and 701 in international
journals in the last three years. Similarly, the faculty at public
institutes published 233 papers in national and 888 papers in the
international journals in the 2007-2010 period. Faculty at the leading
institutes such as Vellore Institute of Technology, SASTRA University
and Jaypee University of the Information and Technology have published
maximum number of papers during the period.
Of the 49 institutes, 32 have conducted campus interviews. About 1,922
students got placed during the campus placements. Meanwhile, over 3,300
students expressed interest in continuing education and research in
this space. The highest salary package offered to a BTech graduate was
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
4.8 lakh to a student from RV College of Engineering in Bangalore. The
average annual highest package for a BTech student offered at the
placement time was
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
3.82 lakh. For the post graduate student the
average highest package offered was
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
3.16 lakh and lowest package
offered was
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
1.94 lakh per annum. For a PhD holder average annual
package offered by the companies was
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
6 lakh.
Jawaharlal Nehru University (JNU) continue to remain a
much-sought-after institute among students who are keen on joining
courses in biotechnology. The JNU received over 2,500 applications for
an intake of 8 PhD seats. Similarly University of Hyderabad and
Institute of Chemical Technology, Mumbai attract a lot of attention
among the students as these received 4,121 applications for 101 seats
and 277 applications for 40 seats for post graduate courses.
However, the question often raised by the industry is how employable is
this talent pool. A lot can be done on this front in the general view.
According to Dr Yogeshwar Rao, senior scientist, Indian Institute of
Chemical Technology (IICT), Hyderabad. “There is a need to create
finishing schools as a part of existing research institutes. Often
there are voices within the industry saying that these graduates are
not employable. Therefore, we need 'advanced learning schools'. Persons
trained in one particular area need to impart added skills in
students.�
“The industry generally feels that the institutes are not creating the
industry-oriented professionals. They might be right, but the
universities generally don't expect their students to work directly in
the industry after their post-graduation courses,� observes Dr Bhat.
The business aspect of the biotech cannot be overlooked for long and it
needs to be put in place at the right time. Otherwise, the whole
industry is set to lose in the long run. There are two ways in
which one can find solution for this. Those having a flair for
corporate world should be given an opportunity in this industry
and at the same time, the research-oriented students should get ample
support to help them in their pursuit. In this regard, the segregation
seems to be one of the keys.
Sujay Shetty, associate director of pharma and life sciences,
PricewaterhouseCoopers, India, says, “There is a strong need for
metrics in education. There is no dearth in courses and programs, but,
we need to introspect on the quality of graduates we are creating.�
The
way forward
The Department of Biotechnology, Government of India, is taking
initiatives to bridge the gap between education and employment by
remodeling the existing educational set up with emphasis on
multidisciplinary research. The other government agencies such as the
Department of Science and Technology, and the Indian Council of Medical
Research are also taking steps to reform the education system.
Dr TS Rao of the Department of Biotechnology, says, “DBT has been
ensuring that there are changes in the educational system. We have been
taking the multidisciplinary approach towards education. The work on
translational research facilities at Faridabad Biocluster is one such
initiative.�
DBT intends to select two to three universities per year across the
nation and then send a team to selected universities to undertake an
analysis of strengths and weaknesses in infrastructure,
inter-disciplinary research programs, skill and leadership gaps. Taking
this initiative further, DBT has selected the Banaras Hindu University
(BHU) and Osmania University for this program. The other universities
included in the program are the state agricultural universities such as
Punjab Agricultural University, Tamil Nadu Agricultural University,
University of Agricultural Science-Dharwad, and G B Pant University of
Agriculture and technology. As part of its long term approach, DBT is
expected to cover about 30 universities by next 10 years. This is due
to the fact that the process of negotiation and engagement is
repetitive, serious and requires critical thinking. So, this time
consuming process limits the ability to handle not more than three
universities per year.
In an interview published in Biotech News, Dr MK Bhan, secretary, DBT,
has rightly put forward the strong need to change the thinking and
attitude towards the universities and research institutes. While
highlighting his point, he said, “Generally the universities are
considered only as education centers and the research institutes as
centers for strategic or applied research. Therefore, the universities
have not been given much attention in terms of funding and support.
Universities lack adequate resources, effective leadership and good
governance. In comparison to this, the research institutes have been
able to attract good faculty due to more resources and adequate
funding.�
Recently, the DBT also invited letter of intent for upgradation,
remodeling and creation of interdisciplinary program of life sciences
(IPLS) for advanced research and education in Central/State
universities. The specific objective is to upgrade the post graduate
teaching and training laboratories in terms of infrastructure and
equipment, appoint new faculty, provide fellowships for students,
introduce training programs, regroup research activities in emerging
areas along the biotech innovation chain (from discovery to market) and
promote academia-industry interaction. The mantra here is innovate or
perish.
India moots HR
strategy for Biopharma
|
According to a note prepared by
FICCI and the Department of
Pharmaceuticals (DOP), the program-based teaching, is the way forward
and has to replace the department-based teaching, in specialty areas.
The primary reason given is that innovation, now lies in combining
subjects, and is not within the domain of any subject. Combinatorial
subjects are the 'new subjects' and can be modified, changed, kept
dynamic, as time goes by. Such additions to the Education and Research
(E&R) HR strategy, according to paper, would augur well to catalyze
the Biopharma Leadership Plan. |
Highlights
1. The paper suggests that the biology as a subject is generally seen
as boring or with uncertain future. Since the modern biology is
different from the traditional biology and has mass appeal, there is
need to draw mathematicians, physicists and engineers to help in
augmenting the speed and depth of biopharma research.
2. The paper emphasizes on industry linkage to help in translational
research by using common knowledge, equipment and science. Apart
from
NIPER, several institutes of DBT, CSIR and some independent ones, are
functioning under DST. These institutes are present all over
India and
if they contribute to the common goal, it would be easier to build upon
their research and develop some innovative products. Also, the
coordination between the industry and these institutes would lead to
the tremendous progress. |
BioSpectrum Bureau